BNP and NT-proBNP levels in patients with sepsis

被引：18
|
作者：
Li, Nan [1 ]
Zhang, Yu [1 ]
Fan, Songtao [2 ]
Xing, Jing [1 ]
Liu, Hongyang [1 ]
机构：
[1] Dalian Med Univ, Emergency Dept, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
[2] Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2013年 / 18卷
关键词：
Systemic Inflammatory Response Syndrome; B-Type Natriuretic Peptide; Multiple Organ Dysfunction Syndrome; Atrial Natriuretic Peptide; Review; BRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; HEART-FAILURE; SEPTIC SHOCK; VENTRICULAR DYSFUNCTION; PROCALCITONIN; BIOCHEMISTRY; MARKER; EPIDEMIOLOGY; DEPRESSION;
D O I：
10.2741/4175
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent years, BNP and NT-proBNP have been the focus of studies evaluating the severity and prognosis of sepsis. In this study, we will review the role of BNP and NT-proBNP in sepsis.
引用
收藏
页码：1237 / 1243
页数：7
相关论文
共 50 条
  • [1] BNP or NT-proBNP?
    不详
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (10) : A104 - A104
  • [2] Inflammation results in increased levels of NT-proBNP and an increased NT-proBNP/BNP ratio
    Jensen, J.
    Ma, L. P.
    Fu, M.
    Hammarsten, O.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 281 - 281
  • [3] Preliminary crossreactivity studies of proBNP, BNP and NT-proBNP in commercial BNP and NT-proBNP assays
    Apple, F. S.
    Luckenbill, K.
    Ler, R.
    Murakami, M. M.
    Christenson, R.
    Jaffe, A.
    Mair, J.
    Ordonez-Llanoss, J.
    Pagani, F.
    Tate, J.
    Wu, A.
    [J]. CLINICAL CHEMISTRY, 2007, 53 (06) : A6 - A7
  • [4] Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio
    Jensen, Juliana
    Ma, Li-Ping
    Fu, Michael L. X.
    Svaninger, David
    Lundberg, Per-Arne
    Hammarsten, Ola
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (07) : 445 - 452
  • [5] Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio
    Juliana Jensen
    Li-Ping Ma
    Michael L. X. Fu
    David Svaninger
    Per-Arne Lundberg
    Ola Hammarsten
    [J]. Clinical Research in Cardiology, 2010, 99 : 445 - 452
  • [6] Evaluating the evidence for assessing BNP and NT-proBNP levels
    Busse, J. W.
    Bassler, D.
    Guyatt, G. H.
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (4-5) : 227 - 230
  • [7] The biomarkers BNP and NT-proBNP
    Oremek, G. M.
    Passek, K.
    Holzgreve, F.
    von der Eltz, V.
    Droege, J.
    [J]. ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2023, 73 (02): : 89 - 95
  • [8] Predictive Role of BNP and NT-proBNP in Hemodialysis Patients
    Sun, Linlin
    Sun, Yan
    Zhao, Xuezhi
    Xu, Chenggang
    Chen, Dongping
    Li, Lin
    Ma, Yiyi
    Rong, Shu
    Mei, Changlin
    [J]. NEPHRON CLINICAL PRACTICE, 2008, 110 (03): : C178 - C184
  • [9] BNP and NT-proBNP in patients with renal failure and haemodialysis
    Baum, H
    von Meyer, A
    Heemann, U
    Hallbach, J
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S112 - S113
  • [10] Plasma concentrations of BNP and NT-proBNP in patients on hemodialysis
    Wahl, H
    Graf, S
    Ashayer, S
    Scheckel, B
    Fassbinder, W
    Renz, H
    [J]. CLINICAL CHEMISTRY, 2004, 50 (06) : A20 - A21
12345